Yuyu Pharma Acquires Treasury Shares Worth 2 Billion KRW... "Continuing Shareholder-Friendly Policy"

[Asia Economy Reporter Lee Gwan-joo] Yuyu Pharma announced on the 19th that it will proceed with the acquisition of treasury shares worth 2 billion KRW.

This treasury stock acquisition will be conducted through on-market purchases on the KOSPI market, with a planned acquisition quantity of 304,878 common shares and an acquisition amount of 2 billion KRW. The acquisition period will be from the 20th of this month to December 19th, lasting three months.

Yuyu Pharma currently holds approximately 570,000 common treasury shares, and upon completion of this treasury stock acquisition, it will hold 5.1% of the total issued common shares as treasury stock.

Previously, Yuyu Pharma has implemented continuous shareholder-friendly policies, including a 1 billion KRW treasury stock repurchase in October 2020 and a 100% free stock dividend last year, allocating one new common share per existing common share.

Yuyu Pharma CFO (Chief Financial Officer) Executive Director Park Noyong stated, "We will continue to strive to enhance the value for our shareholders, including individual investors who trust and invest in Yuyu Pharma's corporate value and growth potential, through shareholder-friendly policies."

This content was produced with the assistance of AI translation services.